BioSpace News Archive

The fifth annual CAR-TCR Summit will kick off in Boston Tuesday with a focus on advancements in immunotherapies targeting various cancers, as well as challenges that face the field.

Rho, a full-service contract research organization, is showcasing its nearly 35-year history of success in drug development strategies and services at the Outsourcing in Clinical Trials Texas 2019 Conference, the newest addition to the Outsourcing in Clinical Trials series, taking place September 11-12 in Houston.

Seizure Onset Zone Located Immediately, Dealt With

ADC Therapeutics SA announced that it has filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission relating to a proposed initial public offering of its common shares.

MaxCyte announces that Director of Field Applications Scientists Christopher Mann, PhD, will present on “Advancing Adoptive Cellular Therapies Using Non-viral-based Engineering” at the 2nd International Conference on Lymphocyte Engineering on Saturday 14 September at 9:50 a.m. BST.

GENFIT announced that Dr. Carol L. Addy has joined the Company as Chief Medical Officer.

Sphere Fluidics introduced the Cyto-Cellect™ Human IgGK Detection Kit, to be used in conjunction with the Cyto-Mine® Single Cell Analysis System for rapid and cost-effective measurement of antibody class and productivity in cell line development.

New role builds on growing interest in BioAscent’s integrated discovery services

‘iM-TCRs’ enable controllable cytotoxicity of tumor-specific TCR-T cells to potentially tune safety and efficacy according to clinical needs

Novel genomics and computational methods reveal how gene “switches” impact survival rates of cancer patients, paving the way to targeted cancer treatments